Novartis AG - Return On Equity

Novartis AG's Fiscal Year is From January To December - All Figures are in Percent.

The item "Return-On-Equity" stands at 34.12 percent as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Return On Equity" stands at 34.12 Percent. This represents an increase of 1.56 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -6.96 percentage points compared to the value the year prior.
The 1 year change in percentage points is -6.96.
The 3 year change in percentage points is -0.3491.

The Serie's long term average value is 29.07 percent. It's latest available value, on 09/30/2025, is 5.05 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +22.75.
The Serie's change in percentage points from it's maximum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is -6.96.